Unusual cutaneous manifestations associated with resistance to activated proteine C;Manifestations cutanees d'une resistance a la proteine C activee

Annales de Medecine Interne

Volumn 149, Issue 2, 1998, Pages 102-104

  Loche, François ^a   Marc, Valérie ^a   Caranobe, Claudine ^a   Bazex, Jacques ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; HUMAN; PHLEBITIS; SKIN MANIFESTATION; AGED; DIFFERENTIAL DIAGNOSIS; GENETICS; MALE; NECROSIS; PATHOLOGY; RECURRENT DISEASE; SKIN; SKIN DISEASE; THROMBOPHLEBITIS;

ACTIVATED PROTEIN C RESISTANCE; AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEG DERMATOSES; MALE; NECROSIS; RECURRENCE; SKIN; SKIN DISEASES, GENETIC; THROMBOPHLEBITIS;

EID: 0031959784     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. DAHLBÄCK B, CARLSSON M, SVENSSON PJ: Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA, 1993 ; 90 : 1004-8.
2. BERTINA RM, KOELEMAN BPC, KOSTER T, et al. : Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994 ; 369 : 64-7.
3. KOSTER T, ROSENDAAL FR, DE RONDE H, et al. : Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet, 1993 ; 342 : 1503-7.
4. SVENSSON PJ, DAHLBÄCK B : Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med, 1994 ; 330 : 517-22.
5. ZÖLLER B, SVENSSON PJ, HE X, et al. : Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest, 1994 ; 94 : 2521-4.
6. RIDKER PM, HENNEKENS CH, LINDPAINTNER K, STAMPFER MJ, EISENBERG PR, MILETICH JP : Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med, 1995 ; 332 : 912-7.
7. EMMERICH J, POIRIER O, EVANS A, et al. : Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet, 1995 ; 345 : 321.
8. EMMERICH J, ALHENC-GELAS M, AIACH M, et al. : Activated protein C resistance: role in venous and arterial thrombosis. Arch Mal Coeur, 1996 ; 6 : 741-5.
9. MUNKVAD S, JORGENSEN M : Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol, 1996 ; 134 : 296-8.
10. PERKINS W, DOWNIE I, KEEFE M, et al. : Cutaneous necrosis in pregnancy secondary to activated protein C resistance in hereditary angioedema. J R Soc Med, 1995 ; 88 : 229-30.
11. MAKRIS M, BARDHAN G, PRESTON FE : Warfarin induced skin necrosis associated with activated protein C resistance. Thromb Haemost, 1996 ; 75 : 523-4.